These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Economic aspects of drug over use. Rucker TD Med Ann Dist Columbia; 1973 Dec; 42(12):609-14. PubMed ID: 4520521 [No Abstract] [Full Text] [Related]
3. Paregoric on prescription. Tice LF Am J Pharm Sci Support Public Health; 1972; 144(2):39-40. PubMed ID: 5068202 [No Abstract] [Full Text] [Related]
4. Use of d-amphetamine and related central nervous system stimulants in children. Pediatrics; 1973 Feb; 51(2):302-5. PubMed ID: 4695865 [No Abstract] [Full Text] [Related]
6. The Bureau of Drug Abuse Control: a review of the first two years. Gunn JW J Forensic Sci; 1968 Jul; 13(3):302-17. PubMed ID: 5757498 [No Abstract] [Full Text] [Related]
7. Drugs, sports and doping. Clarke KS J Maine Med Assoc; 1970 Mar; 61(3):55-8. PubMed ID: 5467145 [No Abstract] [Full Text] [Related]
8. Guiding principles of international and federal laws pertaining to medical use and diversion of controlled substances. Joranson DE NIDA Res Monogr; 1993; 131():18-34. PubMed ID: 8413529 [No Abstract] [Full Text] [Related]
9. Is my colleague overprescribing narcotics? Voth EA Am Fam Physician; 1999 Dec; 60(9):2693-4, 2697. PubMed ID: 10605999 [No Abstract] [Full Text] [Related]
10. FDA actions to prevent prescription drug abuse. Jeske AH Tex Dent J; 2005 Jul; 122(7):634-45. PubMed ID: 16152888 [No Abstract] [Full Text] [Related]
11. [The FBN (Federal Bureau of Narcotics) and the treatment of drug addicts]. Gustafsson A Lakartidningen; 1966 Aug; 63(33):3042-4. PubMed ID: 5975312 [No Abstract] [Full Text] [Related]
12. States respond to growing abuse of painkiller. Wasserman S State Legis; 2001; 27(9):33-4. PubMed ID: 11763873 [TBL] [Abstract][Full Text] [Related]
13. The dentist and prescription drug abuse. Balevi B; Breen L; Krasnowski J J Can Dent Assoc; 1996 Jan; 62(1):56-60. PubMed ID: 8673939 [TBL] [Abstract][Full Text] [Related]
14. Legal perspectives--risk management considerations: I. Duty of care--drug prescription. II. F.D.A. considerations for dentists and auxiliary staff. III. Expert testimony letter. Beal JC Implant Soc; 1996; 6(2):11-4. PubMed ID: 9571850 [No Abstract] [Full Text] [Related]
17. Federal Bureau of Narcotics lists 15 dont's as physician safeguards. J Indiana State Med Assoc; 1970 Feb; 63(2):140. PubMed ID: 5461132 [No Abstract] [Full Text] [Related]
18. Authority for practitioners to dispense or prescribe approved narcotic controlled substances for maintenance or detoxification treatment. Final rule. Drug Enforcement Administration (DEA), Justice Fed Regist; 2005 Jun; 70(120):36338-44. PubMed ID: 15973789 [TBL] [Abstract][Full Text] [Related]